Catalyst Wire Dossier Catalyst Wire Dossier

Narmafotinib

narmafotinib · Amplia Therapeutics Limited
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Narmafotinib, covering 2026-02-23 to 2026-02-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Narmafotinib Given in Combination With Modified FOLFIRINOX in Patients With Metastatic Pancreatic Cancer [Phase 1, Phase 2]

See pricing